# The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy

> **NCT01256021** · PHASE4 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 212 (actual)

## Conditions studied

- Muscle Spasticity

## Interventions

- **DRUG:** Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT01256021
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-02
- **Final completion:** 2011-05
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01256021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01256021, "The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01256021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*